Oleśnica

PIRAMAL PHARMA SOLUTIONS ANNOUNCES PRODUCTION OF FIRST BATCHES AT NEW API FACILITY IN RIVERVIEW, MICHIGAN

Retrieved on: 
Wednesday, February 15, 2023
Aurora, Oleśnica, NSE, Project, API, Pressure, PPL, CAD, Filtration, CDMO, Fine chemical, Piramal

Construction of the capacity expansion at Riverview, known as Project PRIME (Piramal Riverview Integrated Manufacturing Expansion) Phase 1, was kicked off in May of 2021.

Key Points: 
  • Construction of the capacity expansion at Riverview, known as Project PRIME (Piramal Riverview Integrated Manufacturing Expansion) Phase 1, was kicked off in May of 2021.
  • The initial production run is the culmination of a capital expenditure of $38 million in equipment and construction costs.
  • The facility covers approximately 25,000 square feet of space and includes production, warehousing and supporting utilities.
  • According to Peter DeYoung, Chief Executive Officer, Piramal Global Pharma, "Getting Project PRIME Phase 1 online is an important milestone for Piramal Pharma Solutions and the Riverview site team.

PIRAMAL PHARMA SOLUTIONS ANNOUNCES PRODUCTION OF FIRST BATCHES AT NEW API FACILITY IN RIVERVIEW, MICHIGAN

Retrieved on: 
Wednesday, February 15, 2023
Aurora, Oleśnica, NSE, Project, API, Pressure, PPL, CAD, Filtration, CDMO, Fine chemical, Piramal

Construction of the capacity expansion at Riverview, known as Project PRIME (Piramal Riverview Integrated Manufacturing Expansion) Phase 1, was kicked off in May of 2021.

Key Points: 
  • Construction of the capacity expansion at Riverview, known as Project PRIME (Piramal Riverview Integrated Manufacturing Expansion) Phase 1, was kicked off in May of 2021.
  • The initial production run is the culmination of a capital expenditure of $38 million in equipment and construction costs.
  • The facility covers approximately 25,000 square feet of space and includes production, warehousing and supporting utilities.
  • According to Peter DeYoung, Chief Executive Officer, Piramal Global Pharma, "Getting Project PRIME Phase 1 online is an important milestone for Piramal Pharma Solutions and the Riverview site team.

Bilibili Comics announces partnership with Anime-Planet

Retrieved on: 
Wednesday, July 27, 2022
Animation, Industry, Instagram, Twitter, Martial arts, GL, Partnership, Oleśnica, Multimedia, Science, BL, Funimation, Netflix, Book, Entertainment

SINGAPORE, July 27, 2022 /PRNewswire/ --Bilibili Comics is proud to announce a partnership with Anime-Planet, providing free chapters of manga and webtoons to Anime-Planet's online reading portal.

Key Points: 
  • SINGAPORE, July 27, 2022 /PRNewswire/ --Bilibili Comics is proud to announce a partnership with Anime-Planet, providing free chapters of manga and webtoons to Anime-Planet's online reading portal.
  • In addition, Bilibili Comics has added Anime-Planet's community ratings to their pages as part of a new third-party scoring feature.
  • A spokesman from Bilibili Comics said, "We are very optimistic about the cooperation with Anime-Planet, which will allow Bilibili Comics to connect with more comic users.
  • Kim Cameron, Anime-Planet's founder, said: "We are thrilled to have this opportunity to partner with Bilibili Comics.

Piramal Pharma Solutions Invests $10 Million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.

Retrieved on: 
Thursday, June 20, 2019
Silesia, Oleśnica, Oleśnica County, Province of Lower Silesia, Province of Silesia, Dukes of Württemberg, Dukes of Silesia

To date, the Riverview site has had the containment capability and engineering controls to safely handle HPAPIs with OELs down to 1mcg/m3, at scales ranging from grams to ~250 kilos.

Key Points: 
  • To date, the Riverview site has had the containment capability and engineering controls to safely handle HPAPIs with OELs down to 1mcg/m3, at scales ranging from grams to ~250 kilos.
  • It was designed with the required engineering controls and containment solutions to handle HPAPIs with OELs
  • Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle.
  • Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide.

Piramal Pharma Solutions Invests $10 Million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.

Retrieved on: 
Thursday, June 20, 2019
Silesia, Oleśnica, Oleśnica County, Province of Lower Silesia, Province of Silesia, Dukes of Württemberg, Dukes of Silesia

To date, the Riverview site has had the containment capability and engineering controls to safely handle HPAPIs with OELs down to 1mcg/m3, at scales ranging from grams to ~250 kilos.

Key Points: 
  • To date, the Riverview site has had the containment capability and engineering controls to safely handle HPAPIs with OELs down to 1mcg/m3, at scales ranging from grams to ~250 kilos.
  • It was designed with the required engineering controls and containment solutions to handle HPAPIs with OELs
  • Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle.
  • Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide.